Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DIANE RYDER COUNCE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1417989740
CMS profile
290771
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$221,783.68

475 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 4 of 10; records 151–200 of 475 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DIANE RYDER COUNCE

NPI 1417989740 · CMS profile ID 290771

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 10; records 151–200 of 475 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417989740?year=2021&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 10; records 151–200 of 475 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417989740?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 10; records 151–200 of 475 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417989740?year=2021&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 10; records 151–200 of 475 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1417989740?year=2021&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

475 matching records · $221,783.68 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 475 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 475.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $675.0008/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819095001 CMS
Lilly USA, LLC $1,800.0008/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819110525 CMS
Allergan, Inc. $131.3308/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742535 CMS
Allergan, Inc. $4,680.0008/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742537 CMS
Allergan, Inc. $35.0008/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742539 CMS
Allergan, Inc. $22.4008/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742541 CMS
Allergan, Inc. $30.9208/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742543 CMS
Allergan, Inc. $398.7908/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742545 CMS
Allergan, Inc. $35.0008/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742547 CMS
Allergan, Inc. $24.9908/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742549 CMS
Allergan, Inc. $576.4408/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742551 CMS
Allergan, Inc. $36.0008/19/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742553 CMS
AbbVie Inc. $22.4508/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292339 CMS
Allergan, Inc. $1.3908/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742533 CMS
Lilly USA, LLC $12.4008/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819081027 CMS
Novartis Pharmaceuticals Corporation $24.7108/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812645955 CMS
Biohaven Pharmaceuticals, Inc. $22.5508/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469849 CMS
SK Life Science, Inc. $900.0008/16/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826831375 CMS
UCB, Inc. $23.3808/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807297161 CMS
AstraZeneca Pharmaceuticals LP $19.9008/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829542643 CMS
Amgen Inc. $9.2208/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825273821 CMS
Celgene Corporation $11.9308/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783691223 CMS
AbbVie Inc. $3.6008/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292335 CMS
AbbVie Inc. $2.7408/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292337 CMS
Neurelis, Inc. $1,150.0008/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842862233 CMS
Allergan, Inc. $600.0008/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742531 CMS
GENZYME CORPORATION $21.9008/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843542919 CMS
Lundbeck LLC $18.0408/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845903477 CMS
Sunovion Pharmaceuticals Inc. $6.7108/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821915739 CMS
Janssen Pharmaceuticals, Inc $31.8408/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788218985 CMS
Teva Pharmaceuticals USA, Inc. $7.6508/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839514383 CMS
Allergan, Inc. $1.7008/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792742529 CMS
Neurelis, Inc. $17.9008/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842862225 CMS
Neurelis, Inc. $950.0008/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842862229 CMS
Amgen Inc. $20.5508/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825273817 CMS
ACADIA Pharmaceuticals Inc $23.0007/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837995111 CMS
Teva Pharmaceuticals USA, Inc. $20.5107/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839514381 CMS
AbbVie Inc. $4.6507/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292331 CMS
AbbVie Inc. $1.5207/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292333 CMS
Biohaven Pharmaceuticals, Inc. $25.2007/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469845 CMS
AbbVie Inc. $16.1807/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292329 CMS
Biohaven Pharmaceuticals, Inc. $3,400.0007/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469815 CMS
Biohaven Pharmaceuticals, Inc. $781.2307/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469819 CMS
Biohaven Pharmaceuticals, Inc. $101.4007/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469823 CMS
Biohaven Pharmaceuticals, Inc. $79.7207/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469827 CMS
Biohaven Pharmaceuticals, Inc. $1,700.0007/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469831 CMS
Biohaven Pharmaceuticals, Inc. $891.6707/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469833 CMS
Biohaven Pharmaceuticals, Inc. $178.8307/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469837 CMS
Biohaven Pharmaceuticals, Inc. $27.4707/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852469841 CMS
AbbVie Inc. $22.3407/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794292327 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $153,241.17 397
PY2020 $161,693.84 447
PY2021 $221,783.68 475
PY2022 $174,330.11 396
PY2023 $52,932.66 320
PY2024 $45,705.03 345
PY2025 $85,668.96 283

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $51,974.84 28
PY2024 Principal investigator $226,963.03 60
PY2023 Recipient $11,597.38 5
PY2023 Principal investigator $107,834.07 41
PY2022 Principal investigator $95,889.70 33
PY2021 Recipient $7,000.06 2
PY2021 Principal investigator $18,128.90 8
PY2020 Principal investigator $7,100.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,545.00 12/31/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine No dispute reported 06/30/2026 1202534935
Principal investigator 1 ABBVIE INC. $1,082.56 12/31/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Upper Limb Essential Tremor No dispute reported 06/30/2026 1202534937
Principal investigator 1 H. Lundbeck A S $3,990.00 07/10/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251772012
Principal investigator 1 ABBVIE INC. $453.72 07/02/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202496113
Principal investigator 1 H. Lundbeck A S $2,407.00 06/05/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251770767
Principal investigator 1 H. Lundbeck A S $4,228.64 05/15/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251770309
Principal investigator 1 ABBVIE INC. $465.75 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484207
Principal investigator 1 ABBVIE INC. $67.50 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484209
Principal investigator 1 ABBVIE INC. $2,493.45 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484211
Principal investigator 1 ABBVIE INC. $310.50 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484213
Principal investigator 1 ABBVIE INC. $274.20 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484219
Principal investigator 1 ABBVIE INC. $621.00 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484221
Principal investigator 1 ABBVIE INC. $155.25 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484223
Principal investigator 1 ABBVIE INC. $135.00 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484225
Principal investigator 1 ABBVIE INC. $2,660.00 05/07/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202482407
Principal investigator 1 ABBVIE INC. $750.00 05/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202481189
Principal investigator 1 H. Lundbeck A S $3,713.34 04/28/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769886
Principal investigator 1 PFIZER INC. $999.23 04/24/2025 Non-covered Recipient Entity
Achieve Clinical Research LLC
PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE No dispute reported 06/30/2026 1228777565
Principal investigator 1 H. Lundbeck A S $3,990.00 04/22/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769780
Principal investigator 1 Sage Therapeutics, LLC $1,670.50 04/17/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study to Evaluate SAGE-324 in Participants With Essential Tremors No dispute reported 06/30/2026 1206580577
Principal investigator 1 H. Lundbeck A S $3,990.00 03/19/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251768853
Principal investigator 1 ABBVIE INC. $2,333.45 03/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202457860
Principal investigator 1 PFIZER INC. $1,460.50 02/13/2025 Non-covered Recipient Entity
Achieve Clinical Research LLC
PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE No dispute reported 06/30/2026 1228765890
Principal investigator 1 ABBVIE INC. $155.25 02/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202449097
Principal investigator 1 Sage Therapeutics, LLC $3,000.00 02/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor No dispute reported 06/30/2026 1206580572
Principal investigator 1 H. Lundbeck A S $3,990.00 02/05/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251766959
Principal investigator 1 H. Lundbeck A S $1,400.00 01/07/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251766209
Principal investigator 1 ABBVIE INC. $3,633.00 01/02/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202435464